Antioxidative mechanism of Quercus infectoria gall aqueous extract against Candida albicans

Aims@#The effect of Quercus infectoria (QI) gall extract on the fungal expression of antioxidant defense enzymes of Candida albicans was studied in an effort to unravel its anti-fungal mechanism.@*Methodology and results@#Minimum inhibitory concentration (MIC), minimum fungicidal concentration (MFC), and time kill assays were conducted to analyse the antifungal activity of the extract against C. albicans. Total protein profiles of C. albicans were determined by SDS-PAGE and real-time PCR was used to quantify the genes expression level of superoxide dismutase (SOD1), catalase (CAT1) and glutathione peroxidase (GPX3) following treatment with aqueous QI gall extract. The MIC and MFC values of the extract against C. albicans were 8 mg/mL and 16 mg/mL respectively. Fungistatic and fungicidal activities of the extract were observed after 24 h at 1× MIC and 2× MIC from the time-kill assay. A lower total protein bands density of extract-treated C. albicans was visualized when compared to the untreated cells at concentrations of 1× MIC and 2× MIC. A significant reduction in the expression of GPX3 (p 0.05).@*Conclusion, significance and impact of study@#In conclusion, QI gall extract exerted an anti-Candida activity and it is apparently effective in downregulating the gene expression of GPX3 in C. albicans. Of note, the present findings elucidated a preliminary mechanism associated with the organism’s survival resilience which represents a key target for the development of anti-Candida agents in future.

Primary malignant parotid lymphoma: Two case reports with different disease progression and treatment

Objective@#To describe our experience in managing two cases of primary malignant parotid lymphoma. @*Methods@#Design: Case Report Setting: Tertiary University Referral Center Patients: Two @*Results@#Both patients underwent superficial parotidectomy. Despite recurrence in one, the disease was controlled with conservative management. However, the disease was more aggressive in the other, requiring additional chemo-radiotherapy.@*Conclusion@#Malignant parotid lymphoma may present with varying stages, grades and clinical courses, requiring different management approaches. The treatment options are based on grading and staging at diagnosis and should be implemented depending on individual case.

Mastoid Abscess in Acute and Chronic Otitis Media

Background: Mastoid abscess remains a recognised complication of otitis media despite the advent of antibiotics. The objectives of this study were to describe the risk factors in patients with mastoid abscess following acute and chronic otitis media and discuss the management of this infection. Method: A retrospective analysis was done on all patients who underwent mastoidectomy for mastoid abscess from January 2002 to December 2007. Data on the patients’ presentation, associated complications, management, and follow-up were analysed. Results: A total of 12 patients were enrolled in this study population. Group A consisted of patients with mastoid abscess preceded by acute otitis media, while Group B consisted of patients with mastoid abscess and chronic otitis media. In Group A (n = 7), 4 patients had a pre-morbid immunocompromised condition, but they did not have cholesteatoma. None of the patients in Group B (n = 5) had any pre-morbid illnesses. Out of 12 patients, 7 patients had associated extracranial complications, and 1 patient had intracranial complications. Most patients recovered well after mastoidectomy. Recurrence was noted in 1 patient who had acute lymphoblastic leukaemia. Conclusion: Mastoid abscess is still a recognised complication of acute otitis media, especially in patients who are immunocompromised. Immunocompetent patients may also develop mastoid abscess following chronic otitis media associated with cholesteatoma. Thus, early treatment of otitis media and close vigilant follow-up are advocated to ensure prompt detection of mastoid abscess complications.